The QualityStocks Daily Stock List
- Blueberries Medical Corp. (BBRRF)
- CarSmartt, Inc. (CRSM)
- Cobalt 27 Capital Corp. (CBLLF)
- Cool Technologies, Inc. (WARM)
- Copper Mountain Mining Corporation (CPPMF)
- Crexendo, Inc. (CXDO)
- SCI Engineered Materials, Inc. (SCIA)
- Mountain High Acquisitions Corp. (MYHI)
- BioVie, Inc. (BIVI)
- Nanophase Technologies Corp. (NANX)
- Wealthcraft Capital, Inc. (WCCP)
- Protalex, Inc. (PRTX)
- StartMonday Technology Corp. (STMDF)
- Foothills Exploration, Inc. (FTXP)
Blueberries Medical Corp. (BBRRF)
Small Cap Power, Street Insider, PR Newswire, Profit Confidential, Midas Letter, InvestorX, Morningstar, Market Screener, Stockwatch, GlobeNewswire, Wallet Investor, Nasdaq, NIC Investors, Dividend Investor, Stockhouse, Financial Buzz, InvestorsHub, Investing.com, TradingView, and Technical420 reported earlier on Blueberries Medical Corp. (BBRRF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Blueberries Medical Corp. is a Latin American licensed producer of medicinal cannabis and cannabis-derived products. It is a producer of naturally grown premium quality cannabis with its main operations ideally situated in the Bogotá Savannah of central Colombia and operations now being established in Argentina. In Argentina, the Company is advancing a pilot project in a joint venture (JV) with the state-owned company Cannava. A specialized team with proprietary expertise in agriculture, genetics, extraction, medicine, pharmacology and marketing leads the Company. OTCQB-listed, Blueberries Medical is based in Bogotá, Colombia.
The Company is fully licensed for the cultivation, production, domestic distribution, and worldwide export of CBD (cannabidiol) and THC-based (tetrahydrocannabinol) medical cannabis in Colombia. Blueberries Medical’s combination of leading scientific expertise, agricultural advantages and distribution arrangements has positioned it to become a top global supplier of naturally grown, processed, and standardized medicinal-grade cannabis oil extracts and related products.
Regarding cannabis oil extracts, Blueberries develops high-end medicinal products for the treatment of numerous human conditions. The Company works together with small producers in the region of the Bogota Savanna and supplies medicinal cannabis products to the national and global market.
Blueberries Medical has a large cultivation footprint with scalable growing capacity via contract growers. It has 142 exclusive Colombian cannabis strains with high CBD and THC contents. Furthermore, it has strong international partnerships for product development and distribution.
Recently, Blueberries Medical announced the creation of its Medical & Scientific Committee to support management in the development of pioneering formulations and its continuing commercial and educational initiatives. This panel will consist of worldwide respected experts and researchers in pharmaceutical, chemistry, biology, engineering, biochemistry, and medical fields.
Last week, Blueberries Medical announced that it has partnered with The Colombian Society of Pediatrics to host a full-day educational seminar for medical practitioners and other industry participants on the therapeutic benefits of medicinal cannabis and present industry developments. The event is part of Blueberries’ continuing initiatives centered on the development of medical education programs for physicians and patients in Latin America.
The design of this event is to educate pediatricians, pediatric residents, general practitioners, alternative medicine specialists, psychiatrists and other health professionals on the applications and benefits of medicinal cannabis. The event will take place on October 11, 2019 in Bogota.
Blueberries Medical Corp. (BBRRF), closed Tuesday's trading session at $0.14185, up 2.7899%, on 13,256 volume with 13 trades. The average volume for the last 3 months is 70,853 and the stock's 52-week low/high is $0.029999999/$0.649999976.
CarSmartt, Inc. (CRSM)
StockPulse, Trader Newswire, FortuneNewsWire, InvestorBrandNetwork, TipRanks, Market Screener, OTC Markets, Seeking Alpha, Morningstar, GuruFocus, Last10k, TradingView, Stockhouse, PR Newswire, Dividend Investor, Stockopedia, Nasdaq, Wallet Investor, InvestorsHub, Global Banking and Finance Review, and GlobeNewswire reported beforehand on CarSmartt, Inc. (CRSM), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
CarSmartt, Inc. is an American transportation network company (TNC) offering a peer-to-peer ridesharing service. Its platform can be accessed by way of its mobile app (Android and iOS). The Company previously went by the name Sports Supplement Group, Inc. It changed its name to CarSmartt ®, Inc. in February of 2018. CarSmartt has its corporate office in Coral Gables, Florida.
All CarSmartt drivers are subject to background checks to reassure the safety of the Company’s passengers. CarSmartt’s application is made to connect drivers with the world's travelers to make long-distance trips affordable.
The Company’s mission is to democratize mobility and create a liberated ecosystem for road transportation. This means being more economic for drivers, as well as efficient, transparent, eco-friendly, and also higher earnings for drivers.
In May of this year, CarSmartt announced the completion of the new Carsmartt App (iOS and Android). This platform has numerous features that will enable CarSmartt's drivers to earn more money and allow riders to save more on fares. The application can be downloaded at app.carsmartt.com.
In June, the Company announced the results of its initial social media campaign to attract drivers and riders collectively called (Users). As of June 7, 2019, it reached 2336 users in just under two weeks. In June, CarSmartt finalized a partnership with GoodHire, one of the top background check companies in the United States. CarSmartt’s vision is to keep CarSmartt’s security standard the highest in the industry.
Every driver who wants to work with CarSmartt needs to log in to the GoodHire site and submit their information via a link that will be posted on the Company’s website. This ensures third party verification of CarSmartt drivers and increases the level of security significantly.
Last month, CarSmartt announced the hiring of its new Chief Operating Officer, Mr. Nick Bittante, ex-Lyft. Chief Executive Officer, Mr. Roy Capasso said, “I am very excited to welcome our new Chief Operating Officer, Nick Bittante. The Board of Directors was searching for an experienced figure in the startup and rideshare worlds. Nick is the right leader to build upon CarSmartt’s momentum with his unique background of starting companies from scratch and managing at scale.”
CarSmartt, Inc. (CRSM), closed Tuesday's trading session at $0.033208, up 2.4938%, on 108,340 volume with 11 trades. The average volume for the last 3 months is 356,866 and the stock's 52-week low/high is $0.001599999/$0.194999992.
Cobalt 27 Capital Corp. (CBLLF)
OTC Markets, Hottest Stock Picks, Junior Mining Network, Dividend Investor, Market Screener, InvestorsHub, Wallet Investor, Energy and Capital, Streetwise Reports, TradingView, Barchart, MarketWatch, Proactive Investors, Morningstar, PR Newswire, Tip Ranks, GuruFocus, Seeking Alpha, and Metals News reported beforehand on Cobalt 27 Capital Corp. (CBLLF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
OTCQX-listed, Cobalt 27 Capital Corp. is a foremost battery metals streaming company. It offers exposure to metals vital to key technologies of the electric vehicle (EV) and energy storage markets. The Company’s intention is to continue investing in an electric metals-focused portfolio of streams, royalties and direct interests in mineral properties containing cobalt. This is while potentially adding to its cobalt physical holdings when opportunities arise. Cobalt 27 Capital has its corporate office in Toronto, Ontario.
The Company’s strategy of holding physical cobalt, streams and royalties will avoid the operational, environmental, closure and capital risks associated with usual mining companies. Cobalt 27 will not be exposed to any operational risks carried by automakers and battery producers. Through holding physical cobalt and electric metals focused streams and royalties, it will be able to participate in price appreciation while minimizing exposure to risks.
Cobalt 27 Capital holds an 8.56 percent joint venture (JV) interest in the long-life, world-class Ramu operation. At present, this operation delivers near-term attributable nickel and cobalt production. In addition, the Company manages a portfolio of 11 royalties and also owns physical cobalt and a cobalt stream on the Voisey's Bay mine.
This past July, Cobalt 27 Capital reported that it filed a technical report for its recently acquired interest in the low-cost, long-life, Ramu nickel-cobalt operation, prepared in accordance with National Instrument 43-101 - Standards for Disclosure for Mineral Projects (NI 43-101). The Ramu Technical Report is in support of Cobalt 27’s May 17, 2019 news release announcing the acquisition of Highlands Pacific Limited. As such, Cobalt 27 acquired an 8.56 percent JV interest in Ramu, an integrated producing nickel-cobalt operation, situated in Madang Province, Papua New Guinea (PNG).
Earlier in September, Cobalt 27 Capital provided an update in connection with the proposed acquisition of Cobalt 27 by Pala Investments Limited via a plan of arrangement. Pala Investments will indirectly acquire all of the issued and outstanding shares of the Company, other than the roughly 19 percent that Pala already owns, via statutory plan of arrangement. Under the Arrangement, shareholders of Cobalt 27 Capital will receive consideration of C$5.75 per common share, consisting of C$3.57 in cash plus shares of a newly listed company named Nickel 28 Capital Corp. with an implied value of C$2.18 per share.
Moreover, this month, Cobalt 27 Capital announced quarterly production results from its 8.56 percent direct equity interest in the world-class Ramu integrated nickel and cobalt operation. Ramu is one of the few High-Pressure Acid Leaching (HPAL) operations commissioned since 1999 that has met expectations with respect to capacity and cost. In the quarter ending June 30, 2019, Ramu produced 22,490 tonnes of mixed hydroxide product (MHP) containing 8,767 tonnes of Ni and 793 tonnes of Co. Year to date production at Ramu is 16,430 tonnes of contained nickel and 1,497 tonnes of contained cobalt.
Cobalt 27 Capital Corp. (CBLLF), closed Tuesday's trading session at $2.98, off by 0.726892%, on 185 volume with 4 trades. The average volume for the last 3 months is 12,829 and the stock's 52-week low/high is $2.45079994/$5.19140005.
Cool Technologies, Inc. (WARM)
Street Insider, Investing.com, TeleTrader, Emerging Growth, MarketBeat, Market Screener, Wallet Investor, TradingView, Stockhouse, Nasdaq, TipRanks, Morningstar, Last10k, 4-Traders, Dividend Investor, The Street, InvestorsHub, and GlobeNewswire reported previously on Cool Technologies, Inc. (WARM), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Cool Technologies, Inc. is an innovator in efficient mobile electric power generation and power enhancement technologies for motors and generators. It is an intellectual property (IP) and product development enterprise commercializing patented thermal dispersion technology across manifold platforms. The Company previously went by the name HPEV, Inc. It changed its corporate name to Cool Technologies, Inc. in August of 2015. OTCQB-listed, Cool Technologies is based in Tampa, Florida.
The Company operates in three addressable markets. These are Mobile Generation, Motors & Generators, and Pumps. Mobile Generation (MG) removes the need for tow-behind generators. A Proprietary Gearing System draws power from the truck’s engine. MG decreases size and increases the efficiency of the generator.
Motors & Generators removes heat more efficiently and boosts power density. Moreover, it lessens costs by up to 25 percent. Moreover, Pumps – Water and Wastewater - removes extremely high maintenance costs. It also doubles pump output.
Regarding Cool Technologies’ IP for Thermal Technology, 7 patents cover different kinds of heat removal from electric motors, generators, electronics, battery packs, controls, brakes, clutches, and more. All incorporate the innovative application of heat pipes. This past June, Cool Technologies announced that it entered into a joint venture agreement (JV) with KeyOptions Pty Ltd. KeyOptions is a privately-held technology and security provider headquartered in Victoria, Australia.
KeyOptions develops and markets products for governments, defense contractors and other commercial applications to counter security and cyber threats. The Company will provide a license for the JV to market and sell Cool Technologies’ complete product platform in Australia and neighboring countries in Southeast Asia.
Furthermore, in June, Cool Technologies announced that it entered into a JV agreement with KILO, Inc. KILO is a privately held company headquartered near Minneapolis, Minnesota. KILO is an IP company with a pioneering hydrogen creation process that does not involve electrolysis, and requires minimal power. This proprietary technology produces hydrogen from water and subsequently infuses the gas into the fuel system.
The JV includes mutual licenses for each Companies’ technologies. Both companies will market Cool Technologies’ Mobile Generation (MG) systems with the option to include KILO’s HydroQube™ technology and other available options, including water desalinization.
Cool Technologies, Inc. (WARM), closed Tuesday's trading session at $0.024, off by 6.3963%, on 1,142,839 volume with 22 trades. The average volume for the last 3 months is 454,746 and the stock's 52-week low/high is $0.020099999/$0.074.
Copper Mountain Mining Corporation (CPPMF)
Streetwise Reports, Trade Ideas, Mining.com, Silicon Investor, Barchart, Dividend Investor, YCharts, Wallet Investor, Stockwatch, The Online Investor, MarketWatch, Street Insider, TeleTrader, Barchart, Stockhouse, GuruFocus, InvestorsHub, and Trading View reported earlier on Copper Mountain Mining Corporation (CPPMF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.
Copper Mountain Mining Corporation operates as a mining company in Canada. It explores for copper, gold, and silver deposits. Its flagship asset is the 75 percent owned Copper Mountain mine positioned in southern British Columbia near the town of Princeton. Established in 2006, Copper Mountain Mining is headquartered in Vancouver, British Columbia.
The Copper Mountain mine currently produces about 90 million pounds of copper equivalent, with average annual production expected to increase to more than 110 million pounds of copper equivalent in 2020. Furthermore, Copper Mountain Mining has the permitted, development-stage Eva Copper Project in Queensland, Australia. It also has an extensive 4,000 km2 highly prospective land package in the Mount Isa area.
The expectation is that the Copper Mountain mine will have a 26 year mine life and produce an average of 116 million pounds of copper equivalent per year (with a modest mill expansion and integration of New Ingerbelle). In addition, the permitted development-ready Eva Copper Project in Queensland, Australia is expected to contribute an additional approximately 100 million pounds of copper equivalent per year when in production.
Copper Mountain Mining announced in February 2019 a new integrated life of mine production plan for its Copper Mountain Properties in southern British Columbia. The Integrated Production Plan includes a modest expansion of the existing Copper Mountain Mine (CMM) mill to 45,000 tonnes per day (tpd) and integrates production from New Ingerbelle.
The results include a 102 percent increase in Mineral Reserves, a 27 percent increase in average annual copper equivalent production to 116 million pounds (over the first ten years), a 12-year extension in mine life to the above-mentioned 26 years and a decrease in C1 cash costs to US$1.87 per pound produced, versus the previous CMM production plan included in the Company's 2018 NI 43-101 Technical Report for the Copper Mountain Mine, filed in November 2018.
Recently, Copper Mountain Mining announced Q2 2019 financial and operating results. Production for Q2 of 2019 was 22.1 million pounds of copper equivalent (consisting of 18.4 million pounds of copper, 6,922 ounces of gold and 65,707 ounces of silver). Revenue for Q2 of 2019 was $65.1 million , from the sale of 17.9 million pounds of copper, 7,044 ounces of gold and 55,276 ounces of silver, net of pricing adjustments. Earnings per share (EPS) was $0.01. Adjusted EPS was $0.00 for Q2 of 2019.
Yesterday, Copper Mountain Mining announced that after many years of leadership at the Company, Mr. James O'Rourke resigned as Chair of the Board and as a Director with immediate effect. Mr. O'Rourke is a 2005 recipient of the Edgar A. Scholz Medal for Excellence in Mine Development in British Columbia and the Yukon. He is also the 2010 recipient of the Mining Person of the Year award for British Columbia. Additionally, Mr. O'Rourke received the Order of British Columbia in 2011 and was inducted into the Canadian Mining Hall of Fame in 2013.
Copper Mountain Mining Corporation (CPPMF), closed Tuesday's trading session at $0.5249, off by 0.152178%, on 10,625 volume with 2 trades. The average volume for the last 3 months is 25,421 and the stock's 52-week low/high is $0.479999989/$0.950600028.
Crexendo, Inc. (CXDO)
NetworkNewsWire, Zacks, InvestorVillage, Stockhouse, Seeking Alpha, Simply Wall St, Tip Ranks, Wallet Investor, Barchart, YCharts, Market Screener, Capital Cube, InvestorsHub, Stockwatch, MarketWatch, Last10k, Wallmine, 4-Traders, and MarketBeat reported earlier on Crexendo, Inc. (CXDO), and we also report on the Company, here at the QualityStocks Daily Newsletter.
Crexendo, Inc. is an award-winning first-rate provider of cloud communications, UCaaS (Unified Communications as a Service), call center, collaboration services for businesses, and other cloud business services. The design of these is to provide enterprise-class cloud services to any size business at affordable monthly rates. Crexendo is a full-service cloud communications provider. The Company is headquartered in Tempe, Arizona and lists on the OTC Markets’ OTCQX.
Crexendo delivers critical voice and data communication services to small, medium, and small enterprise markets. The Company is PCI and HIPPA compliant. In addition, Crexendo is a registered CLEC, licensed for its cloud, telecommunications and network family of services.
The Company’s solutions include phones, mobile, cloud and call center. Furthermore, Crexendo’s solutions include collaboration, integrations, unified communications, and features. Important features for enhancing business communications and productivity include business dashboard, call recording, cloud communicator, SMS & Chat, and the above-mentioned collaboration. Important features additionally include cloud fax, unified messaging, as well as full feature suites.
In late August, Crexendo announced that TMC awarded the Crexendo Cloud Communicator a 2019 Communications Solutions Product of the Year Award. TMC is a worldwide, integrated media company. This is the third time that Crexendo has been awarded the coveted Communications Solutions Product of the Year Award. Moreover, Crexendo earlier announced the award of the 2019 Unified Communications Product of the Year Award for the same application.
Mr. Doug Gaylor, President and Chief Operating Officer (COO), stated, "Our award-winning platform and applications help our customers improve their businesses by making them more efficient and productive while at the same time usually saving them a considerable amount on their monthly telecom spend.”
Crexendo's Cloud Communicator provides award winning UCaaS solutions. This allows businesses the ability to manage phone calls, text messages, conferences, voicemail, video, chat, CRM, and instant messaging within the Crexendo platform. The Company’s patented solutions include a comprehensive hosted phone system with enterprise-grade features, a user-friendly portal, and strong mobile applications.
Crexendo, Inc. (CXDO), closed Tuesday's trading session at $3.50, even for the day, on 4 volume with 1 trade. The average volume for the last 3 months is 4,889 and the stock's 52-week low/high is $1.53999996/$4.00.
SCI Engineered Materials, Inc. (SCIA)
Zacks, Market Screener, Morningstar, GuruFocus, 4-Traders, Investors Hangout, Wallet Investor, InvestorsHub, MarketWatch, Dividend Investor, Simply Wall St, Stockopedia, Marketwired, MarketBeat, Street Insider, YCharts, Last10k, and Financial Content reported previously on SCI Engineered Materials, Inc. (SCIA), and today we report on the Company, here at the QualityStocks Daily Newsletter.
SCI Engineered Materials, Inc. is an international supplier and manufacturer of advanced materials for physical vapor deposition (PVD) thin film applications. The Company works closely with end users and original equipment manufacturers (OEMs) to develop unique, customized solutions. SCI offers ceramic targets, metal sputtering targets, and backing plates for use in semiconductors, flat panel displays, photonics, glass, thin film batteries, transparent electronics, and thin film solar products. Formed in 1987, SCI Engineered Materials has its head office in Columbus, Ohio.
The Company’s materials are used to produce nano layers of metals and oxides for advanced material systems. In addition, they are used in applying decorative coatings for end uses, including sink faucets to produce diverse electronic, photonic, as well as semiconductor products. SCI Engineered Materials serves domestic and multi-national corporations, universities, and research institutions. SCI distributes its products directly, and via independent manufacturers' representatives in the U.S., and independent distributors and manufacturers' representatives globally.
SCI Engineered Materials is starting to manufacture thin film solar products in China. With a joint agreement with publicly-owned Konfoong Materials International Co., LTD (KFMI), KFMI will bond rotatable thin film solar Aluminum Zinc Oxide (AZO) cylinders produced in Columbus, Ohio for thin film solar customers in China.
Furthermore, SCI will transfer its bonding technology for rotatable sputtering targets. KFMI will invest in new equipment for this manufacturing process. SCI Engineered Materials’ products for photonics and thin film solar customers in areas other than China will continue to be bonded at its manufacturing facility in Columbus, Ohio.
Last month, SCI Engineered Materials reported results for the six months and three months ended June 30, 2019. Mr. Jeremy Young, Company President and Chief Executive Officer, stated, “We achieved a 54 percent increase in revenue and an 11 percent increase in gross profit for the first six months of 2019 compared to last year. Second quarter gross profit margin increased sequentially from the first quarter and was lower than the same period in 2018 due to product mix.”
SCI Engineered Materials, Inc. (SCIA), closed Tuesday's trading session at $1.56, off by 3.1056%, on 200 volume with 2 trades. The average volume for the last 3 months is 3,865 and the stock's 52-week low/high is $1.44000005/$4.75.
Mountain High Acquisitions Corp. (MYHI)
Wealth Insider Alert, SmallCapVoice, Wallstreet Profiler, FivedollarMovers, Stockgoodies, Laissez Faire Today, Integrity Solution IR, Cannabis Financial Network, TopPennyStockMovers, Market Intelligence Center, Charms Investments, StreetAuthority Daily, and PennyDoctor reported earlier on Mountain High Acquisitions Corp. (MYHI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Mountain High Acquisitions Corp. is a turnkey, pioneering infrastructure provider to licensed cannabis growers, processors, and producers in regulated markets. The Company assists in the design, permitting, development, and operation of scalable infrastructure. OTCQB-listed, Mountain High Acquisitions is based in Scottsdale, Arizona.
Additionally, the Company helps licensed operators take advantage of scientific and technological innovations specifically geared to optimize the cultivation and processing of cannabis. In 2017, Mountain High Acquisitions entered into an agreement with D9 Manufacturing, Inc. D9 Manufacturing is an Arizona-based business that provides a wide variety of engineering, manufacturing, and consulting services to the cannabis sector.
Mountain High Acquisitions engaged D9 Manufacturing to assist in the identification, acquisition, and development of infrastructure and technology opportunities in the emerging cannabis market. Mountain High, together with D9 Manufacturing, has launched a pilot project targeted at proving a turnkey infrastructure model Mountain High intends to launch in highly promising cannabis markets. This includes California, Washington, and Arizona. The goal is to assist licensed cannabis growers in overcoming the key business challenge of financing steep start-up infrastructure expenses.
Mountain High Acquisitions has expanded its pilot program focused on providing turnkey infrastructure solutions to licensed cannabis growers. With the help of D9 Manufacturing, the program agenda has expanded to include the development of reliable Standard Operating Procedures (SOPs), which growers will be able to use to substantially reduce the risk of low yield or failed grows. D9 Manufacturing is concentrating on fine-tuning SOPs and best practices.
Mountain High Acquisitions announced in August of 2018 that it closed on the acquisition of One Lab Co. One Lab is a Nevada-based company that provides extraction equipment to the cannabis industry.
Recently, Mountain High Acquisitions announced that its wholly-owned subsidiary One Lab Co. completed delivery of a state-of-the-art modular extraction lab to Workforce Labor Solutions, LLC (WLS). WLS provides turnkey labor and extraction services to licensed cannabis producers in Washington State. According to the terms of the five-year lease with One Lab, WLS will make payments of $25,000 per month for use of the lab.
Mountain High Acquisitions Corp. (MYHI), closed Tuesday's trading session at $0.01262, up 22.5243%, on 2,016,762 volume with 81 trades. The average volume for the last 3 months is 226,143 and the stock's 52-week low/high is $0.009499999/$0.07.
BioVie, Inc. (BIVI)
NetworkNewsWire, Penny Stock Tweets, Stockhouse, Investor Place, Wallmine, Wealth Insider Alert, InvestorsHub, Morningstar, YCharts, EuroInvestor, MarketWatch, GuruFocus, Street Insider, and Simply Wall St reported earlier on BioVie, Inc. (BIVI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
BioVie, Inc. focuses on the discovery, development, and commercialization of unique drug therapies for liver disease. At present, the clinical-stage Company is centering on commercializing BIV201. This is a novel approach to the treatment of ascites due to chronic liver cirrhosis. OTCQB-listed, BioVie has its corporate headquarters in Beverly, Massachusetts.
The Company states that BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, NASH, and alcoholism. The US Patent and Trademark Office (USPTO) issued US Patent No. 9,655,945 covering BioVie’s new drug candidate BIV201.
BIV201 has Orphan Drug designation for the most common of these complications, ascites, which represents a major unmet medical need. The Food and Drug Administration (FDA) has never approved any drug specifically for treating ascites.
BIV201 is a continuous infusion of the peptide terlipressin, first undergoing development for the treatment of refractory ascites. Terlipressin, dosed differently, is approved in about 40 nations for other complications of liver cirrhosis coming up from a similar disease pathway. Terlipressin is not available in the United States.
BioVie announced in April 2017 that it received notice from the FDA that the planned Phase 2a clinical trial of its new drug candidate BIV201 could begin. This was based on BioVie’s IND to conduct a study in patients with refractory or intractable ascites due to advanced liver cirrhosis. BioVie also announced in April 2017 the signing of a Cooperative Research and Development Agreement (CRADA). This is to conduct a Phase 2a clinical trial of BIV201 in patients with refractory or intractable ascites because of advanced liver cirrhosis.
The FDA has granted Fast Track designation for BIV201 (continuous infusion terlipressin), BioVie’s patented Orphan drug candidate. BIV201 is currently undergoing evaluation for the treatment of refractory ascites because of liver cirrhosis in a mid-stage (Phase 2a) U.S. clinical trial.
The FDA has granted Orphan Drug designation to BioVie for terlipressin for the treatment of hepatorenal syndrome (HRS). BioVie earlier secured an Orphan Drug designation for terlipressin for treating ascites. The Company is exploring additional Orphan designation opportunities.
Recently, BioVie announced that it completed enrollment in a Phase 2a open-label clinical study of BIV201 (continuous infusion terlipressin) in patients with refractory ascites because of advanced liver cirrhosis.
Patrick Yeramian, MD, BioVie’s Chief Medical Officer, said, “We are pleased to have achieved this important clinical milestone as we continue to develop BIV201 for patients with refractory ascites who are at high risk of deadly complications. What we have learned from this initial study is informing our next clinical trial design. The results will be presented to the FDA in the first half of 2019 and we expect to receive guidance on the BIV201 clinical development plan.”
BioVie, Inc. (BIVI), closed Tuesday's trading session at $0.0716, up 30.1818%, on 92,254 volume with 17 trades. The average volume for the last 3 months is 55,021 and the stock's 52-week low/high is $0.052499998/$0.119999997.
Nanophase Technologies Corp. (NANX)
Schaeffer’s, StockEgg, Stealth Stocks, CoolPennyStocks, Wall Street Resources, SmarTrend Newsletters, Investment Contrarians, RedChip, Profit Confidential, BullRally, Stock Rich, HotOTC, and Penny Invest reported previously on Nanophase Technologies Corp. (NANX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Nanophase Technologies Corp. is a technology leader in nanomaterials and advanced nanoengineered products. The Company provides nanoengineered solutions for numerous industrial product applications. Nanophase assists its customers in succeeding, with proprietary and patent protected technologies. These technologies allow them to create unique products. OTCQB-listed, Nanophase Technologies is based in Romeoville, Illinois.
Nanophase delivers commercial quantity and quality nanoparticles, coated nanoparticles, and nanoparticle dispersions in a variety of media. The Company produces engineered nanomaterial products for use in an array of markets. These markets include Surface Finishing, Exterior Coatings, Personal Care, Plastics, Scratch Resistant Coatings, as well as Textiles.
Nanophase’s products include Aluminum Oxide, Antimony Tin Oxide, Bismuth Oxide, Cerium Oxide, Iron Oxide, and Zinc Oxide. Nano metal oxides provide UV protection across plastics, exterior coatings, and textile applications. Infrared absorbing particles create high clarity, energy saving films and interlayers.
The Company’s nano and submicron Aluminum Oxide imparts scratch resistance to coatings for wood, laminates, packaging, graphic arts, and electronics. Nano metal oxide technology improves the durability and capacity of zinc anode-based batteries.
Regarding nanoparticle surface treatment, Nanophase Technologies utilizes patented and proprietary particle coating technology to tailor the surface of the nanoparticles by discreetly encapsulating individual particles. The process can be used to impart a broad spectrum of functionality to the particles that, in addition to helping to ensure success in the application, provides the Company’s customers with a considerable deal of flexibility in formulation with the nanoparticles. Nanophase Technologies can provide the products in dry powder or pre-dispersed formats.
Concerning nanoparticle production technology, the traditional and most customary manufacturing methods used at the Company are plasma-based. The Physical Vapor Synthesis (PVS) and NanoArc® Synthesis (NAS) methods use transferred and non-transferred electric arcs to vaporize precursor materials. These are then carefully condensed to produce nanoparticles with desired properties.
Pertaining to Dispersion Technology, the Company has developed dispersed product formats for all of its nanocrystalline metal oxides. These concentrated dispersions are manufactured using an assortment of polar and non-polar organic solvents, water, as well as monomers as the continuous phase. The proprietary chemistry and process technology employed to prepare these dispersions ensures that Nanophase’s customers receive ready-to-use products in which the nanoparticles are stabilized at their primary particle size, with no secondary structure or agglomeration.
Nanophase Technologies Corp. (NANX), closed Tuesday's trading session at $0.47, up 27.027%, on 11,151 volume with 8 trades. The average volume for the last 3 months is 9,092 and the stock's 52-week low/high is $0.260199993/$0.899999976.
Wealthcraft Capital, Inc. (WCCP)
OTC Markets, MarketWatch, InvestorsHub, 4-Traders, Stockhouse, Simply Wall St, WalletInvestor, Penny Stock Hub, Penny Stock Tweets, Barchart, Stock Target Advisor, InvestorPlace, and Silicon Investor reported on Wealthcraft Capital, Inc. (WCCP), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Wealthcraft Capital, Inc. concentrates on the investment of capital in private companies, which are interested in expanding their business through gaining better access to capital, management consulting, as well as business development. Mr. Adam D. Sexton is the President and Chief Executive Officer (CEO) of the Company.
Mr. Sexton is an experienced business, entertainment, and digital media leader. He has wide-ranging experience launching and operating disruptive digital products and services for worldwide entertainment, technology industry leaders, as well as start-ups.
Wealthcraft Capital was previously known as Wealthcraft Systems, Inc. It changed its name to Wealthcraft Capital, Inc. in February of 2017. The Company’s shares trade on the OTC Markets Group’s OTCQB. Wealthcraft Capital has its corporate headquarters in Los Angeles, California.
Recently, WealthCraft Capital announced the acquisition of a majority interest in Geaux Industries in exchange for $1,000,000 of the Company’s common stock at market value. Geaux Industries is a provider of security services for commercial, retail and industrial customers, with customized services and special patrol methods applicable for the cannabis industry.
Geaux Industries is licensed by the California Department of Consumer Affairs. For selected security operations, Geaux does business under the franchised name of Signal 88 Security. The exchange agreement provides for Wealthcraft Capital to acquire the minority interest, under certain terms and conditions.
Mr. Sexton said, “With the legalization of recreational cannabis in California on January 1, 2018, the Company believes that there is a significant market opportunity for Geaux Industries to be one of the leading providers of specialized security services.”
Geaux Industries will continue to address the market with inventive new technologies and services and creative business models for the traditional and non-traditional businesses.
At the closing, Wealthcraft Capital CEO, Adam Sexton, was appointed to fill a vacancy on the Board of Directors of Geaux Industries.
Wealthcraft Capital, Inc. (WCCP), closed Tuesday's trading session at $0.35, off by 7.8947%, on 39,325 volume with 15 trades. The average volume for the last 3 months is 1,261 and the stock's 52-week low/high is $0.172000005/$0.899999976.
Protalex, Inc. (PRTX)
StreetInsider, Zacks, TopStockAnalysts, and OTCPicks reported on Protalex, Inc. (PRTX), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
Protalex, Inc. is a clinical-stage Biopharmaceutical Company based in Florham Park, New Jersey. Its emphasis is on the development of a class of drugs for treating autoimmune and inflammatory diseases. These include RA (Rheumatoid Arthritis) and ITP (Immune Thrombocytopenia). The Company’s lead product is PRTX-100. This is a formulation of a proprietary, highly purified form of Staphylococcal Protein A, which is an immunomodulatory protein produced by bacteria. Protalex’s shares trade on the OTC Markets Group’s OTCQB.
Rheumatoid arthritis (RA) is an autoimmune disease. RA is a disorder in which the body’s immune system mistakenly attacks the joints. Immune Thrombocytopenia (ITP) is a blood disorder. ITP can result in easy or excessive bleeding and bruising because of the body’s inability to form blood clots.
Pre-clinical data indicate that PRTX-100 may have the potential to treat ITP through reducing the immune-mediated destruction of the platelets. Protalex has open IND’s for the treatment of RA and ITP in the United States, and in Europe, an open IMPD for ITP.
Protalex’s PRTX-100 can (at very low concentrations) bind to human B-lymphocytes and macrophages and to modulate immune processes. PRTX-100 has been granted Orphan Drug Designation in the United States and in Europe for the treatment of ITP. This status provides commercial exclusivity benefits, tax credits for certain research, potential research grants and a waiver of the New Drug Application user fee in the United States. Currently, it is the subject of clinical studies in the U.S. and Europe.
PRTX-100 is administered as a short intravenous infusion. The following patents have been granted for PRTX-100: U.S. Patent No. 9,370,552 (‘552 patent) is a continuation patent to initial U.S. patent No. 7,211,258 (Protein A compositions and methods of use) filed in 2002 and issued with method of treatment claims for RA, juvenile RA, and systemic lupus erythematosus (SLE). The ‘552 patent expands the method of treatment of PRTX-100 to include type 1 diabetes.
European Patents No. 2,570,136 and 2,206,511 (national patents in place in France, Germany, Italy, Spain, Switzerland, and the UK) includes composition claims relating to numerous autoimmune diseases (RA, ITP, juvenile RA, psoriasis, myasthenia gravis) and dosage expansion.
Canadian patents No. 2,894,098 and No. 2,481,282 comprise method of treatment claims relating to RA and SLE. Japanese patent No. 5,523,796 claims compositions for treating psoriasis, scleroderma, Crohn’s Disease, myasthenia gravis, ulcerative colitis, psoriatic arthritis, as well as pemphigus vulgaris.
Recently, Protalex announced that following a planned interim analysis of data from the fourth dose cohort of its European Phase 1b study of PRTX-100 (PRTX-100-203 Study) in adults with persistent/chronic Immune Thrombocytopenia (ITP), it initiated enrollment in the fifth and highest dose cohort of this dose-escalating study.
The first patient in the final cohort was recently dosed in the United Kingdom at 24 micrograms/kg. This the highest dose of PRTX-100 used in any clinical trial to date. One of the three patients treated in the fourth dose cohort (18 micrograms/kg) attained a protocol defined platelet response.
Protalex, Inc. (PRTX), closed Tuesday's trading session at $0.0061, up 22.00%, on 40,105 volume with 10 trades. The average volume for the last 3 months is 4,550 and the stock's 52-week low/high is $0.000199999/$0.261249989.
StartMonday Technology Corp. (STMDF)
Dividend Investor, OTC Markets, Stockhouse, MarketWatch, Barchart, GuruFocus, Science of Stocks, Investorx.ca, and Penny Stock Hub reported on StartMonday Technology Corp. (STMDF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
StartMonday Technology Corp. engages in candidate selection solutions for employers in the retail and hospitality sectors. The Company helps employers choose better candidates, quicker, with the power of 15-second video introductions. A smart recruitment technology enterprise, StartMonday Technology has its corporate headquarters in Vancouver, British Columbia. The Company’s shares trade on the OTC Markets Group’s OTCQB.
StartMonday Technology was founded by professionals from the recruiting and tech fields - Ray Gibson from recruiting and HR, and Andrew Evans from the founding team at Careerbuilder.com.
StartMonday Technology’s commitment is to building strong tools for the Mobile Generation. Moreover, the Company is further developing its technology with an open blockchain solution for verifiable career histories named CareerChain.
StartMonday's video-led mobile and web applications deliver a better impression of customer skills and personality, ultimately assisting employers in deciding which candidates they should talk to first. This makes the process much more efficient.
StartMonday's core products center around 15-second videos filmed by candidates on their own mobile phones and web browsers. This puts job applications decisively in the social media and mobile native arena.
This enables job seekers to present themselves in their own way. In addition to lessening cost and time-to-hire, the Company brings massive employer branding opportunities to its clients.
Recently, StartMonday Technology announced that it has partnered with Talent Tech Labs (TTL)- Manhattan-based, as part of their late-stage accelerator program targeted at advancing select, mature startups ready for targeted penetration into the North American market. Talent Tech Labs is a sector leader in the knowledge and analysis of up-and-coming trends and technologies applied to improving the state of the art of recruitment.
StartMonday Co-Founder and Chief Executive Officer, Mr. Ray Gibson said, “We are extremely pleased to have been selected for the TTL accelerator program. This is a limited and very influential opportunity that has previously proven its worth at propelling entry into the U.S. marketplace… We believe this program will ideally position us to really show what StartMonday and CareerChain can do to accelerate success within the HR industry arm of Corporate America.”
StartMonday Technology Corp. (STMDF), closed Tuesday's trading session at $0.10, up 400.00%, on 8,350 volume with 2 trades. The average volume for the last 3 months is 828 and the stock's 52-week low/high is $0.0076/$0.100000001.
Foothills Exploration, Inc. (FTXP)
MarketWired, OTC Markets, and InvestorsHub reported on Foothills Exploration, Inc. (FTXP), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Foothills Exploration, Inc., through its wholly-owned subsidiary, Foothills Petroleum, Inc. (a Nevada corporation), is an early stage independent oil and gas exploration and production company. It involves in the acquisition and development of oil and gas properties in the Rockies. The Company’s goal is to acquire dislocated and underdeveloped oil and gas assets and maximize those assets. Foothills Exploration is headquartered in Denver, Colorado.
The Company’s strategy is to build a balanced portfolio of E&P assets through concentrating on acquiring producing and developmental properties in the Rockies and focusing on the generation of high-impact oil and gas exploration projects. Foothills Exploration’s goal is to build a land bank of more than 200,000 acres of proven, probable, and prospective reserves.
Currently, Foothills Exploration holds 41,181 acres in the Greater Green River Basin in Wyoming. Its Springs Prospect consists of 38,120 contiguous acres. This is a multiple objective oil resource play in the Greater Green River Basin.
Moreover, the Company has a 35 percent Working Interest (WI) in the Ladysmith Anticline prospect. This prospect is in Fremont County, Wyoming. Ladysmith Anticline in entirety amounts to 3,061 acres. Its location is between the Great Divide/Greater Green River Basin and the Wind River Basin.
Foothills also has its PawPaw Project. The Pawpaw project is a 3-D seismic defined prospect. It covers 4,467 acres and is a direct analog to the highly productive Tensleep Formation “Enigma” Field positioned two miles south.
The Company also has its Ironwood Project. The Ironwood Project is a 6,115-acre up dip field extension play. The adjacent “Cotton Creek” Field produced about 67 million barrels of oil (MMBO) and 68 billion cubic feet of gas (BCFG), chiefly from the Phosphoria Formation.
Foothills Exploration announced in February 2017 that since acquiring Tiger Energy Partners International on December 30, 2016, Foothills has successfully reworked two wells in its Duck Creek project obtaining production from the Green River formation.
Regarding the Duck Creek Area – Natural Buttes Field, Foothills Exploration plans to re-enter two wells in September in the Duck Creek region situated in Uintah County, Utah, in the Natural Buttes field. The Duck Creek wells recently had a third-party engineering report completed. The Report calculated a total PV-10 value of $707,000 of Proved Developed Producing and Proved Developed Non-Producing reserves.
Concerning the Altamont- Bluebell and Brundage Canyon areas, a third-party reserve report was conducted on certain properties, which were acquired via the Tiger Energy Partners International acquisition. According to this Report, the properties have roughly 5.4 million barrels of Proved Undeveloped Reserves. The well depths range from 5,500 feet in the Brundage Canyon area to roughly 18,000 feet in the Altamont-Bluebell area.
Foothills Exploration, Inc. (FTXP), closed Tuesday's trading session at $0.0235, up 35.0575%, on 467,396 volume with 39 trades. The average volume for the last 3 months is 92,153 and the stock's 52-week low/high is $0.014999999/$0.680000007.
The QualityStocks Company Corner
- Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF)
- INmune Bio Inc. (NASDAQ: INMB)
- Geyser Brands Inc. (TSX.V: GYSR)
- Xalles Holdings Inc. (OTC: XALL)
- Sharing Services Global Corporation (SHRG)
- Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF)
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF)
- Pressure BioSciences Inc. (PBIO)
- Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)
- The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)
- Earth Science Tech, Inc. (ETST)
- Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF)
- Marijuana Company of America (OTCQB: MCOA, MCOAD)
- Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE)
Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF)
Chemistree Technology Inc. (CSE: CHM and CHM.wt) (US OTCQB: CHMJF) (the "Company" or "Chemistree"), is pleased to provide shareholders with an update on the Company's Washington State assets. Chemistree has received a strongly positive report from the general manager of its Washington state licensee partner detailing the successes as previously reported in April have in fact been exceeded.
Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF), an investment company focused on the U.S. and international cannabis sectors, provides turnkey solutions for the regulated cannabis industry. The company leverages managements' expertise and decades of experience in the cannabis industry to acquire and develop vertically integrated cannabis assets. Chemistree recently closed on a purchase of prospective cannabis cultivation property in California, made a first investment in the Canadian cannabis industry, owns assets in the State of Washington used to operate an established retail cannabis brand, and has an active pipeline of assets in place to grow its portfolio.
Chemistree offers industry leading expertise across all areas the cannabis business and in its growth as a public or private company.
- Investment and funding for rapid growth
- Vertical integration solutions
- Construction, design and/or optimization of indoor or outdoor cultivation facilities
- Reputation management & influencer outreach
- Branding and Packaging
- Social Media and Media outreach
With the marketing of cannabis companies and their products in its infancy, the company believes the industry offers tremendous opportunity for growth in the U.S. and abroad. Chemistree initially targeted the Pacific Northwest for investment and, following its recent California property purchase, expects to expand vertically across the United States in areas where it has a competitive business advantage.
Through its wholly owned CHM Desert LLC subsidiary, Chemistree owns 9.55 acres of undeveloped land in Desert Hot Springs, California. The property is zoned as Light Industrial Lands Designated for Marijuana Cultivation, and local zoning ordinances allow as a conditional use the location of up to three onsite cannabis cultivation buildings of 68,000 square feet each, along with support space that would support production of 55,000 pounds/year.
Through its wholly owned Chemistree Washington Ltd. subsidiary, Chemistree acquired physical assets used in the cultivation, production and distribution of cannabis. The Washington assets are currently under lease to Sugarleaf Farm LLC, which operates the Sugarleaf brand of retail cannabis products in the State of Washington. Sugarleaf Farm is a Tier 3 cannabis producer and processor whose products are sold in about 125 retail outlets. Chemistree has indicated the relationship with Sugarleaf may provide the company with additional opportunities to become involved in the marketing of Sugarleaf products.
Chemistree funded these acquisitions and investments with the proceeds of two non-brokered private placement financings completed earlier this year under the regulations of the Canadian Securities Exchange, totaling CAD$4.5 million. In conjunction with the private placements, the company was granted approval by the CSE for a change of business to become an Investment Issuer. This funding is expected to provide the company "maximum flexibility to take advantage of the numerous opportunities available in the cannabis industry in Canada and the U.S."
Chemistree also has a strategic investment in Pasha Brands Ltd., a British Columbia based cannabis company with multiple internationally recognized brands. Pasha has a proven history in cannabis retailing and its proposed Licensed Processing (LP) facility on Vancouver Island is in the final stage of the application for government approval. The LP facility is expected to assist in licensing selected craft growers of cannabis and expanding the distribution of locally grown product. The investment represents less than 10% of Chemistree's working capital.
Company Chairman Justin Chorbajian is co-owner of the largest chain of privately owned hydroponic retail shops in Canada. He also cofounded a group of companies that manufacture and distribute hydroponic equipment. He is a frequent contributor to Growing Exposed, the leading video series dedicated to cannabis cultivation. Company President Karl Kottmeier is a former investment advisor with 20 years of experience listing, financing and administering companies on the Toronto Stock Exchange and TSX Venture Exchange. He has raised more than $150 million in equity capital for ventures. Chemistree CFO Doug Ford has been general manager of Dockside Capital Group Inc., a private merchant banking and venture capital firm serving emerging growth companies. Sheldon Aberman, the most recent member of the Board, has managed, designed and created industry leading grow room designs around the world. Additionally, he has built several leading brands such as Frost Box and Black Label and is an expert in the accessory market (vape pens, silicon mats and extraction tools etc.).
Data firm Statista has forecast the U.S. legal cannabis market will be worth more than $24 billion by 2025. New Frontier Data, which focuses exclusively on the cannabis industry, projects the value of the Canadian domestic cannabis market that same year at CAD$9.2 billion.
Chemistree Technology Inc. (CHMJF), closed Tuesday's trading session at $0.15005, up 4.3826%, on 18,558 volume with 13 trades. The average volume for the last 3 months is 25,965 and the stock's 52-week low/high is $0.097000002/$0.605000019.
- Chemistree Provides Washington State Update from Sugarleaf
- 420 with CNW – Radio Frequency Technology Tweaked to Protect Marijuana Quality
- 420 with CNW – The American Bar Association Asks Congress to Pass Legislation Allowing States to Enact Their Own Cannabis Laws
INmune Bio Inc. (NASDAQ: INMB)
RJ Tesi, M.D., co-founder and CEO of clinical-stage immunology company INmune Bio (NASDAQ: INMB), was recently featured in an interview with multimedia financial reporter Jason Lin. Among other highlights, Dr. Tesi discusses recent company accomplishments in the interview. To view the interview, visit: http://nnw.fm/fGd1c. To view the full press release, visit: http://nnw.fm/2NBFd.
INmune Bio Inc. (NASDAQ: INMB) is a diversified clinical-stage immunology company developing novel therapies that target distinct parts of a patient's innate immune system to fight disease. Drug candidates INKmune™ and INB03 may be used to treat cancer while XPro1595 targets neuroinflammation as a cause of Alzheimer's disease. INmune Bio's product platforms utilize a precision therapy approach to promote the body's innate immune response to treat unsolved problems in medicine.
INmune Bio is the first biotechnology company to close an initial public offering (IPO) in 2019 and commence trading on The Nasdaq Capital Market. The company also received a "Part the Cloud" award from the Alzheimer's Association in 2018 which included a $1 million grant to advance INmune Bio's XPro1595 drug candidate.
INmune Bio's product pipeline targets three segments of concern:
- Alzheimer's disease/dementia claims 5.5 million patients in the United States. INmune Bio views Alzheimer's as an immunologic disease which changes the drug discovery process, changes the way clinical trials are designed, and may provide hope for patients and caregivers.
- Cancer residual disease which is expected to generate more than 1.7 million new cases yearly with an estimated 609,640 fatalities. INMB believe that converting resting Natural Killer ("NK") cells to primed NK cells, which kill cancerous cells on contact, is an important therapeutic strategy to help clear residual disease.
- Resistance to immunotherapy. By preventing the proliferation and function of cells that resist immunotherapy, patients should have a stronger immune response to cancer cells and may respond better to other cancer treatments including immunotherapy and live longer.
INmune Bio Drug Candidates and Clinical Programs
INKmune is a biologic delivery system that primes a patient's resting NK cells to kill cancer. INKmune targets residual disease for patients that have completed initial cancer therapy (surgery, radiation and/or chemotherapy) and have a low burden of disease with a high risk of relapse.
In late 2019, INKmune will start enrolling patients in a phase I/II trial for women with relapsed refractory ovarian cancer. In many patients, cancer relapse after seemingly effective cancer therapy is due to a failure of the patients own NK cells to eliminate minimal residual disease ("MRD").
Using a novel mechanism of action and a precision medicine approach, INKmune therapy should enhance NK cells' ability to eliminate residual disease.
INB03 is a checkpoint inhibitor that targets myeloid derived suppressor cells ("MDSC") which can produce an immunosuppressive shield that prevents a patient's own immune system from attacking the cancer. INmune Bio is currently completing a monotherapy INB03 phase I trial in patients with advanced solid tumors. The INB03 program will transition into a combination therapy clinical program in the summer of 2019 to prepare for a phase II trial in patients resistant to checkpoint inhibitors due to increased MDSC.
Treatment with INB03 should eliminate MDSC in the tumor microenvironment to allow checkpoint inhibitors to be therapeutically effective.
XPro1595 targets the microglial immune cells of the brain that are activated in many Alzheimer's disease patients. These microglial cells are a cause of neuroinflammation that can kill nerve cells and promote synaptic dysfunction – the cause of dementia in Alzheimer's.
The three-month, phase I trial is expected to enroll 18 patients in summer of 2019. It is designed to measure traditional and novel biomarkers of inflammation in patients with mild to moderate Alzheimer's disease who have neuroinflammation. The trial is supported by a $1 million "Part the Cloud" grant from the Alzheimer's Association. Inflammation, especially chronic inflammation, is being recognized as an important part of the pathology of many diseases including cancer and Alzheimer's disease.
Dr. RJ Tesi, M.D., INmune Bio co-founder, CEO and acting chief medical officer, has been a licensed physician since 1982 and a Fellow of the American College of Surgery since 1991. He received his medical degree from Washington University School of Medicine in 1982 and has served many roles in several development-stage biotech companies focused on treatment of neurodegenerative diseases, hematologic malignancies, and other inflammatory diseases.
CFO David J. Moss co-founder, has been with the company since its formation in September 2015. He holds an MBA from Rice University and a bachelor's degree in economics from the University of California, San Diego. Moss has founded, funded and taken public various companies in a variety of industries since 1995.
Mark Lowdell, Ph.D. co-founder, has served as the chief scientific officer and chief manufacturing officer at INmune Bio since the company's formation. He is a professor of cell and tissue therapy at University College London where he has led a translational immunotherapy group since 1994. He has also been a director of cellular therapy at the Royal Free London NHS Foundation Trust. He received his Ph.D. in clinical immunology from London Hospital Medical College, University of London in 1992 and is a qualified immunopathologist.
Christopher J. Barnum is director of neuroscience at INmune Bio. Barnum is a neuroimmunologist with broad expertise across neurodegenerative and psychiatric diseases holding multiple positions in academic and industry. His focus has been on translating inflammatory therapies into clinical treatments for neurologic diseases using a biomarker-directed approach. Barnum's research has been supported by the NIH, the Michael J. Fox Foundation, and the Alzheimer's Association. He received his Ph.D. in neuroscience from Binghamton University.
INmune Bio Inc. (OTC: INMB), closed Tuesday's trading session at $5.64, up 1.6216%, on 22,527 volume with 167 trades. The average volume for the last 3 months is 27,495 and the stock's 52-week low/high is $5.05999994/$11.50.
- INmune Bio, Inc. (NASDAQ: INMB) CEO Discusses Company Achievements in Interview; Director of Neuroscience to Present at World Immunotherapy Congress
- INmune Bio to Present XPro1595 for Treating Neuroinflammation in Alzheimer’s Disease at 2019 Alzheimer’s Association International Conference (AAIC) Satellite Symposium
- INmune Bio, Inc. (NASDAQ: INMB) Executives to Speak, Showcase Innate Compounds at Two Upcoming Events
Geyser Brands Inc. (TSX.V: GYSR)
Geyser Brands Inc. (TSX-V: GYSR) ("Geyser Brands" or the "Company) is very pleased to announce the receipt of their Natural Product Number (NPN) from Health Canada for their hemp-based pain relief roll-on. Through the issuance of the NPN, Geyser Brands' Solace subsidiary (see press release dated September 18, 2019) is authorized to market and sell their Pain Relief Roll-on as a natural health product through the Apothecary Naturals line of products. Licensed products have been assessed by Health Canada and found to be safe, effective and of high quality under their recommended conditions of use.
Geyser Brands Inc. (TSX.V: GYSR) is a consumer healthcare company that builds and markets some of the world's most loved cannabis products and brands in the nutraceutical, cosmetics, food and beverage and pet sectors. Using its proprietary nanotechnology formulation, the company delivers creams, beverages, baked goods and tincture formulations with superior bioavailability and water solubility.
The efficacy of most hemp?products is restricted as the insoluble nature of the molecules prevents most of the product from permeating the skin or entering the body system. Geyser Brands solves this insolubility problem with an advanced delivery system that quickly and efficiently transports therapeutic agents directly to the bloodstream for maximum absorbency.
Made with all-natural materials, NanoFusion technology offers an array of advantages: enhances penetration for deeper skin penetration; improves the transport of active ingredients for site-specific targeting; delivers active ingredients across cell membranes for release within the cell; provides longer shelf-life and stability of molecules.
Geyser Brands operates a 7,000-square-foot facility in Port Coquitlam, British Columbia, where its initial cannabis cultivation generated the first revenues out of the company's cultivation license granted in October 2018. Geyser Brands is approved as a licensed producer in compliance with Health Canada standards, which allows the company to pursue its processing and sales license. Obtaining this license will enable the company to extend its products and brands into the regulated Canadian cannabis market and directly to the consumer medical market.
Geyser Brands's integrated production chain and formulation lab develops innovative products using high-quality hemp and CBD for healthy lifestyle brands while its R&D lab produces product formulations designed to enhance bio-availability of hemp and CBD and shelf stability while maintaining all-natural ingredients and ensuring premium quality.
Geyser Brands will continue to seek opportunities to invest into the research and development of unique high-quality proprietary strains and technologies that target specific health-related conditions such as pain and inflammation reduction, insomnia, digestive issues and other commonly known ailments.
Among the brand formulations in Geyser Brand's portfolio are:
- Apothecary all-natural Hemp Terpene Pain Cream with optimal skin permeation
- Prohibition Cold Brew Mocha designed with water soluble hemp molecules
- Apothecary health products created to deliver fast-acting and high bioavailability in a spray formulation
- Baked hemp infused pet products, designed to alleviate anxiety and pain, created with NanoFusion for dosage control
Since 2014, Geyser Brands' CEO and Co-Founder Andreas Thatcher has been a principal at Rhizome Group, an entertainment company focused on building media IP through creative and market development. He previously was a founding partner at Rhizome Capital LLC, a U.S.-based media?investment?company specializing in marketing and distribution financing, and worked in the Investment Banking industry in?London and Toronto. Thatcher holds a master's degree in economics.
CFO Barry McKnight obtained his bachelor's degree from the University of British Columbia and is a Chartered Professional Accountant and?Certified Management Accountant registered in British Columbia. McKnight has over 20 years of experience as the principal of Barry D. McKnight Inc. He formerly was also a director of Indigo Sky Capital Corp. and has been the CFO and a director of the Company since 2016 and Corporate?Secretary of the Company since 2017.
Geyser Brands's Co-Founder Brad Kersch brings a strong business background with over 20 years of experience in?successful startups and working?with Fortune 500 companies. He spent his early years in the advertising and?marketing field and went on to form Hyperware, a clothing?company that sold branded clothing to retailers across Canada?before selling to clothing giant Ocean Pacific (OP). Kersch?became the president of Shoreline Studios, Canada's largest and?oldest?studio for film and TV. In 2014 he started Solace Management Group, a hemp product company focused on pet, cosmeceutical, and nutraceutical markets. As of February 2019, Geyser Brands signed a non-binding LOI to acquire Solace Management. Upon completing the proposed Solace acquisition, Geyser Brands intends to launch into the execution phase of its plan — to take its brands global through retail and digital direct-to-consumer experiences, launching its hemp-infused cannabis brands and products in the U.S., European Union, and Asia, and its CBD-infused line of products in jurisdictions where the therapeutic ingredient is legal.
Kuldip Gill, head of Geyser Brands' R&D program, has more than 35 years of experience in the cannabis industry. Gill built the largest manufacturing facility?in the lower mainland in Surrey, British Columbia, complete with R&D, analytical and quality control labs approved by both the FDA and Health Canada. He has to date created over 3,500 formulas, most notably Lakota pain relief gel. Gill's experience and proven track record is evident in the strongly marketable formulations he has developed and sold worldwide.
Geyser Brands Inc. (TSX.V: GYSR), closed Tuesday's trading session at $0.49, up 8.8889%, on 500 volume with 1 trade. The average volume for the last 3 months is 2,381 and the stock's 52-week low/high is $0.409999996/$0.850000023.
- Geyser Brands' Subsidiary Receives Natural Health Product Number from Health Canada
- Geyser Brands Inc. (TSX.V: GYSR) Demonstrates Growth with Encouraging Financial Results
- 420 with CNW – Governor Cuomo Hints Cannabis Smoking Ban Could Be Included in Next Legalization Bill
Xalles Holdings Inc. (OTC: XALL)
Xalles Holdings Inc. (OTC: XALL), a fintech holding company leveraging blockchain and other technologies for e-commerce, payments, financial reconciliation, and payment auditing solutions, today announces it has selected the corporate communications expertise of NetworkNewsWire ("NNW").
Xalles Holdings Inc. (OTC: XALL) is a fintech holding company leveraging blockchain and other technologies for e-commerce, payments, financial reconciliation, and payment auditing solutions. The company actively seeks acquisition targets with strong management teams and business models, large total attainable markets, and lucrative exit opportunities in which to invest and accelerate growth.
The common element to all acquired entities and projects is a business model that involves setting up a payment or financial transaction “toll gate,” thereby creating a recurring revenue stream.
Xalles’ business plan focuses on consumer, business and government-oriented payment and financial reconciliation transactions. Combining the blockchain decentralized financial ledger platform with the company’s existing X2X transaction reconciliation system design, Xalles is building technology that supports payment audits, exchanges, and new business models and opportunities worldwide. Xalles will launch new services card and mobile payment and rewards systems, and will expand the technology offerings for referral marketing and e-commerce engines.
All current subsidiaries are wholly owned
- Xalles Holdings
Raise capital for fintech accelerator program acquisitions, provide management, administrative, finance and marketing support to all subsidiary companies
- Xalles Capital
Management support of investment consortiums, direct investment into funds or projects, and management of investments
- Xalles Limited
Design and market new X2X solutions; acquire U.S Government transportation post-payment audit business through GSA schedule and expand to non-transportation payment auditing
- Xalles Technology
Technical development of the X2X blockchain systems
- Xalles Financial Services
Consumer and small business financial service offerings
- Co-Owners Rewards
Stock-based rewards system for payments cards and financial services
- Amazing Living Enterprises
Affiliate program and e-commerce platform for enhancing financial lives
- Global Savings Network
Not-for-profit fundraising system with consumer discounts at local merchants
Xalles provides payment and financial transaction management solutions through the company’s proprietary blockchain-based X2X technology. The X2X solution includes the Investment and Financing System (IFS), which supports complex investment structures, assists international investment consortia, and provides links to Xalles’ Financial Transaction Reconciliation (FTR) solution. FTR supports complex financial ecosystems, making it easier for parties to exchange products, services, grants and government incentives, and assists “Exchange Managers” with liquidity and auditability. X2X also supports the Xalles pre- and post-payment auditing services.
Advancements in 2019
- Co-Owners Rewards subsidiary is working to launch a general purpose reloadable prepaid payment card with a stock rewards program.
- Previously announced LYC Mortgage acquisition will create a structure that will dramatically increase revenues in 2020 with new mortgage business portfolios.
- Xalles Financial Services expects to launch the Cryptocurrency Trading Engine and acquire multiple cryptocurrency asset portfolios to drive increases in value through the trading engine.
“The structure and growth plan for the company contains a balance of diversity and synergy so that we can effectively use limited resources to obtain the best results. We will see the culmination of the fundraising efforts, acquisitions and organic growth in the second half of 2019 put us on the path to tremendous growth in 2020.”
– Xalles CEO Thomas Nash (http://nnw.fm/rU6iT)
Xalles Holdings Inc. (OTC: XALL), closed Tuesday's trading session at $0.0038, up 11.7647%, on 641,502 volume with 12 trades. The average volume for the last 3 months is 3,219,775 and the stock's 52-week low/high is $0.0013/$0.021029999.
- Coverage Initiated for Xalles Holdings Inc. via NetworkNewsWire
- Xalles Holdings Inc. (XALL) Targets Growing B2B Financial Reconciliation Market
- Xalles Announces Partnership with ATN Trading to Expand Distribution of Powerful Crypto Trading Engine
Sharing Services Global Corporation (SHRG)
At its August 29 annual board meeting, Sharing Services Global Corporation (OTCQB: SHRG) shareholders elected previously announced board members John “JT” Thatch, Keith R. Halls and Kip H. Allison. Thatch, SHRG’s CEO, was elected as a board member through the company’s annual meeting in 2022, Allison was elected through the 2021 annual meeting and Halls was elected through the annual meeting of 2020 (http://nnw.fm/Y9ONV).
Sharing Services Global Corporation (SHRG), headquartered in Plano, Texas, is a diversified holdings company focused on reshaping how entrepreneurs succeed today. Sharing Services Inc. owns, operates or controls an interest in a variety of companies specializing in the direct selling industry that either sell products to the consumer directly through independent representatives or offer services that range from health and wellness, energy, technology, insurance services, training, media and travel benefits. SHRG has created the “Blue Ocean Strategy,” which melds three keys together to implement the company’s vision. These keys include elevating home-based entrepreneurs, known as “Elepreneurs,” utilizing the direct selling channel to generate 100 percent organic growth.
Sharing Services Inc. subsidiaries include:
- A growing international network of home-based entrepreneurs, called “Elepreneurs”
- Growing selection of health and wellness products dedicated to elevating the well-being of all people
- Insurance from auto, home and life to health benefit discounts and health insurance that help families elevate their options
- Wholesale travel and payment programs with travel concierges that empower more families to go on vacation
- Live seminars and training events – from Vacationars™ to EduTainment – that elevate the skills and knowledge of entrepreneurs around the world
- Unique compensation and reward programs crafted to help entrepreneurs elevate their health, wealth and happiness
Sharing Services recently expanded its corporate footprint by moving to a 10,000 square foot facility in Plano, Texas, that offers room to expand as the company grows and its subsidiaries flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.
“The opportunity to expand to the rest of this new building over the course of the next six to 12 months ensures we won’t have to move again anytime soon,” Sharing Services Inc. Chairman Robert Oblon said. “We are on track for very significant growth here in the U.S., as well as upcoming international expansion, so this move is in preparation for what’s in front of us.”
The company recently signed a joint venture agreement with Health Wealth & Happiness Limited (“HWH”) to expand its “Elepreneurs” brand and market its products throughout Asia. The newly formed company will be named “Elepreneurs Asia Limited” and will have marketing and sales rights to China, Hong Kong, Macau, South Korea, Japan, Taiwan, Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, Vietnam and Papua, New Guinea. A soft launch of the Elepreneur program is scheduled sometime later in 2018 with HWH CEP Fai Chan and his team leading the effort. Formed in Hong Kong, Health Wealth & Happiness Limited is dedicated to working with visionary partners like Sharing Services Inc. to deliver the best products and services to improve the well-being of consumers.
Nearly 1,000 people attended Sharing Services Global Corporation ’s first “Elepreneur Happiness Convention,” held March 2-3, 2018, in Dallas, Texas. Attendees arrived from several countries including the U.S., Canada, Mexico, Singapore and Hong Kong. Keynote speakers included several internationally known motivational leaders – Shawn Achor, Sandra Yancey, John Fleming and Les Brown – who provided exceptional material and inspirational discussion points.
“The enthusiasm of our attendees and the early success that we are experiencing is incredible considering our growth has been 100 percent organic, with almost no marketing from the company,” Oblon said. “I’m speechless by the dedication of our Elepreneur leaders and their entire teams, as they share our incredible line of products that have helped so many people.”
Sharing Services and its management team plan to travel the U.S. to hold several mini conferences to expand on the messages presented at its Happiness Convention that focus on helping people become “healthier, happier and wealthier.” Details of the company’s aggressive global expansion initiatives are soon to be announced, Oblon said.
The law firm of Gardere Wynne Sewell LLP has been retained as outside corporate counsel for all general business matters. The Dallas-based law firm will represent Sharing Services Global Corporation , and its subsidiaries as the company utilizes the direct selling channel for a significant component of its overall growth strategy.
John “JT” Thatchwas appointed president and chief executive officer of Sharing Services Global Corporation , at a March 1, 2018, annual shareholder meeting. Thatch has successfully started, owned and operated several sized businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist Sharing Services Inc. as the company aims to expand and increase revenues.
Sharing Services Global Corporation (SHRG), closed Tuesday's trading session at $0.15, up 22.9508%, on 13,000 volume with 1 trade. The average volume for the last 3 months is 32,697 and the stock's 52-week low/high is $0.090000003/$0.3944.
- Sharing Services Global Corporation (SHRG) Announces Shareholder Election Results
- Sharing Services Inc. (SHRG) Assists in Independent Distributors’ Success
- Sharing Services Inc. (SHRG) Adds Value to Management Team with New Appointments
Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF)
Narbe Alexandrian, President & Chief Executive Officer, Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF), joined Rob Peterman, Vice-President, Global Business Development, Toronto Stock Exchange & TSX Venture Exchange, to open the market. Canopy Rivers is an investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers Inc. graduated and commenced trading on Toronto Stock Exchange on September 9, 2019.
Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.
Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.
Canopy Rivers’ expanding portfolio includes:
- Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
- CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
- Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
- James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
- LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
- PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
- Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
- Solo Growth (TSXV:ALZ) is a new cannabis retail concept that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Solo Liquor Stores Ltd., a leading Canadian liquor retailer. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy.
- Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
- TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
- Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.
As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.
Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.
Canopy Rivers Inc. (CNPOF), closed Tuesday's trading session at $1.7212, up 1.2471%, on 40,359 volume with 108 trades. The average volume for the last 3 months is 108,596 and the stock's 52-week low/high is $1.59000003/$5.80999994.
- Canopy Rivers Inc. Opens the Market
- 420 with CNW – Radio Frequency Technology Tweaked to Protect Marijuana Quality
- Tech Disruption Driving the Cannabis Sector
Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)
Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) (“PLUS”), a leading cannabis branded products company based in California, today announced that it has launched a new line of its best-selling cannabis-infused gummies. PLUS debuted its new product line this past week at the Hall of Flowers cannabis tradeshow in Santa Rosa, California, rolling out three new flavors of gummies developed by PLUS’s team of scientists, entrepreneurs and chefs under their recently announced cannabis system: (a) a balance cucumber lime that has 3.5mg THC and 1.5mg CBD per piece; (b) an uplift tangerine that has 5mg THC and <0.1mg CBD per piece; and (c) an unwind concord grape that has 4.5mg THC and 0.5mg CBD per piece.
Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.
First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.
PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.
Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.
During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:
- Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
- Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
- Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
- Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
- Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
- Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.
“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”
The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.
Plus Products Inc. (PLPRF), closed Tuesday's trading session at $3.26, off by 5.5072%, on 45,602 volume with 104 trades. The average volume for the last 3 months is 35,938 and the stock's 52-week low/high is $2.51999998/$6.00810003.
- PLUS Products Launches New Line of Best Selling Gummies in California
- Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Debuts Hemp-CBD Edible Line, Partners with John Legend
- Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Completes Debt Transaction
Pressure BioSciences Inc. (PBIO)
Pressure BioSciences Inc. (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, expects its total revenues to more than double in 2020 following the successful launch of its revolutionary CBD (cannabidiol) processing system – the BaroShear K45. This novel processing system creates a water-soluble CBD oil that disperses instantly in liquid, providing enhanced quality and bio-absorption (http://nnw.fm/4fGre).
Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.
The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.
Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”
Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.
The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.
Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.
This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.
The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.
Pressure BioSciences Inc. (PBIO), closed Tuesday's trading session at $2.66, off by 7.9585%, on 13,007 volume with 32 trades. The average volume for the last 3 months is 35,938 and the stock's 52-week low/high is $1.25/$4.0999999.
- Pressure BioSciences Inc. (PBIO) Issues Update on Guidance for Revenue Growth and Success of Revolutionary CBD Oil Processing System
- Pressure BioSciences’ PCT Platform Identified as Pivotal for Cancer Biomarker Discovery and for Potential Clinical Diagnostics
- Pressure BioSciences, Inc. Discusses Major Advancements Its PCT, BaroFold, and BaroShear K45 Platforms
Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)
Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) today announced it will report results for the fourth quarter and fiscal year 2019 ending June 30, 2019, at approximately 5:00 PM ET on Wednesday, October 23, 2019. Also today, the company was highlighted in a publication from Financialnewsmedia.com, examining how, as cannabis legalization spreads, another drug may soon follow in its footsteps — psilocybin mushrooms.
Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.
In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.
Products under the Green Growth Brand umbrella include:
- CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
- Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
- Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
- Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
- The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
- XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.
Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.
Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.
Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.
Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.
CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.
CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.
Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.
Green Growth Brands Inc. (OTCQB: GGBXF), closed Tuesday's trading session at $1.14, off by 3.3898%, on 181,685 volume with 203 trades. The average volume for the last 3 months is 400,260 and the stock's 52-week low/high is $1.11000001/$5.20499992.
- Green Growth Brands to Hold Fourth Quarter and Fiscal Year 2019 Earnings Conference Call on October 24, 2019
- Why the Magic Mushroom Story Could be as Big as the Cannabis Boom
- Green Growth Brands Announces Resignation of Board Member
The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)
The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) was featured today in a publication from Motley Fool, examining how sales growth and profits have been hard to come by when it comes to marijuana stocks in Canada. While rising sales may be the norm, a strong bottom line isn't always.
Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”
Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.
In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.
“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”
The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.
Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.
7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.
Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.
Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.
To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.
Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.
Supreme Cannabis Company Inc. (OTC: SPRWF), closed Tuesday's trading session at $1.00, off by 4.7619%, on 536,194 volume with 555 trades. The average volume for the last 3 months is 402,290 and the stock's 52-week low/high is $0.850000023/$1.87999999.
- Green Growth Brands to Hold Fourth Quarter and Fiscal Year 2019 Earnings Conference Call on October 24, 2019
- Multiple Reports Agree That Cannabis Market Growth Shows No Signs of Slowing
- Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Releases of Q4 and 2019 Fiscal Year End Financial Results
Earth Science Tech, Inc. (ETST)
Earth Science Tech Inc. (OTCQB: ETST) is an innovative science-based biotechnology company operating in the fields of hemp-derived cannabinoids, nutraceuticals, pharmaceuticals, medical devices and research and development (R&D). The company, based in Doral, Florida, recently announced its establishment of a new sales division specifically focusing on CBD products of therapeutic and pharmaceutical grades.
Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.
Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:
- Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
- Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
- KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.
Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.
In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.
The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.
Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.
Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.
The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.
Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.
Earth Science Tech, Inc. (ETST), closed Tuesday's trading session at $0.492, off by 13.6842%, on 81,673 volume with 52 trades. The average volume for the last 3 months is 46,906 and the stock's 52-week low/high is $0.300999999/$2.45000004.
- Earth Science Tech Inc. (ETST) Appoints Experienced Head of New CBD Sales Division, Files Securities Registration Statement
- Earth Science Tech Inc. (ETST) Positioning as Key Player in Billion-Dollar Industry
- Earth Science Tech Inc. (ETST) Reports Sharp Increase in Revenue, Gross Profit in Quarterly Report
Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF)
Petroteq Energy Inc. (TSXV:PQE; OTC:PQEFF; FSE: PQCF), a fully integrated surface oil sands clean recovery mining oil company with proprietary technology, is pleased to announce that the Company has recommenced production today from the Asphalt Ridge Facility in Utah.
Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) is a Canadian-registered, publicly traded company engaged in the development and implementation of proprietary technologies for the environmentally safe extraction of heavy oils from oil sands, oil shale deposits and shallow oil deposits. The company is focused on oil sands exploration and production on mineral leases in Vernal, Utah, and in expanding production capacity at its Asphalt Ridge heavy oil extraction facility in Utah.
Petroteq Energy’s patent-pending application is a closed-loop, solvent-based process, which results in significantly lower per-barrel production costs than those incurred with traditional hot water-based oil sands extraction technologies. This green technology utilizes a small, modular footprint, produces no greenhouse gases, requires no high temperatures, leaves only clean dry sand, and could be deployed to unlock heavy oil deposits located around the world.
The Company’s Asphalt Ridge mineral lease on 2,500-plus acres in northeastern Utah features a large contingent oil sands resource base with an estimated 87 million barrels of oil equivalent. In 2015, the company produced 10,000 barrels of oil from the Utah location and plans to increase production are underway. Utah holds over 32 billion barrels of undeveloped oil sands resources, which are also known as “oil-wet” deposits containing a mixture of sand and a dense, extremely viscous form of petroleum referred to as bitumen or tar. A recent upswing in developing domestic energy sources has intensified interest in technological advances such as Petroteq’s Clean Oil Recovery Technology (CORT) System.
The Company continues to evaluate the development of other medium to heavy oil exploration, production and recovery projects on a global basis through a variety of structured agreements. These opportunities or other arrangements with private and governmental entities that utilize Petroteq Energy’s proprietary licensed technologies are expected to generate a significant return on investment.
The Company’s management team, board of directors and officers form an invaluable cross-section of industry leaders with extensive experience ranging from chemical engineering and solvent research, business development, international project management, entrepreneurial achievements, and senior management for global energy companies in North America and the Middle East. This impressive knowledge base covers both conventional and unconventional oil and gas projects and production, both in upstream and downstream industry sectors.
Petroteq Energy is also participating in a blockchain initiative aimed at solving the global transaction needs of the oil and gas industry through the development of PetroBLOQ. PetroBLOQ recently joined the Enterprise Ethereum Alliance (“EEA”), the world’s largest open-source blockchain initiative. Membership with the 200-member EEA represents a wide variety of industries and offers 14 industry-focused, member-driven working groups.
“Joining this community of forward-looking enterprises and blockchain innovators is an important step for PetroBLOQ as we develop transformative solutions for the oil and gas industry,” said Petroteq Energy Chairman Alex Blyumkin.
In addition, Petroteq has joined the American Petroleum Institute (API). The API is the only national trade association representing all facets of the oil and natural gas industry, promoting safety across the industry globally and influencing public policy in support of a strong, viable oil and natural gas industry.
“API has led the development of operating standards for our industry, and we look forward to contributing our experience with oilfield technologies in addition to introducing our PetroBLOQ platform to its members throughout the supply chain,” Blyumkin previously stated.
Petroteq Energy Inc. (PQEFF), closed Tuesday's trading session at $0.2533, off by 9.1463%, on 128,830 volume with 38 trades. The average volume for the last 3 months is 241,712 and the stock's 52-week low/high is $0.112099997/$1.01999998.
- Petroteq Announces Recommencement of Production at Asphalt Ridge Facility
- Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) Demonstrates Potential of Clean-Oil Recovery Technology
- Petroteq Announces Commissioning of Asphalt Ridge Facility
Marijuana Company of America Inc. (MCOAD)
Marijuana Company of America (OTCQB: MCOA, MCOAD) was featured today in the 420 with CNW by CannabisNewsWire. Traumatic brain injury is a condition that is more common than most people care to admit. Research estimates that two million-plus people visit the ER each year with cases related to TBI. These cases occur from events such as car accidents, falls and physical attacks, and they result in minor concussion or severe traumatic brain injury. Fifty percent of the TBI injuries are connected to falls by children between the ages of 1-14 years and old folks over the age of 60. The World Health Organization lists TBI among the leading causes of death in young children.
Marijuana Company of America Inc. (OTC: MCOAD) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.
The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.
The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.
The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.
Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.
Marijuana Company of America Inc. (MCOAD), closed Tuesday's trading session at $0.14, off by 11.1675%, on 191,681 volume with 143 trades. The average volume for the last 3 months is 286,206 and the stock's 52-week low/high is $0.023/$2.10599994.
- 420 with CNW – Benefits of Marijuana to People with Traumatic Brain Injury
- Marijuana Company of America Inc. (MCOAD) Joint Venture Provides Low-Cost, Premium-Cannabis Delivery
- 420 with CNW – Former FDA Boss Hints Marijuana Legalization Is Necessary for Public Health Reasons
Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE)
Pacific Rim Cobalt (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) today announced results from its ongoing 2019 shallow drilling program at its flagship Cyclops, nickel/cobalt development project, Indonesia. The drilling is part of a multi-faceted exploration program focused to confirm historical results and guide a project development plan. To view the full press release, visit: http://nnw.fm/Qo3Nl.
Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) is a Canada-based exploration company focused on the acquisition and development of production-grade cobalt deposits, a key raw material input for the growing lithium-ion battery industry.
Pacific Rim Cobalt and its Cyclops Nickel-Cobalt Project, located in the Depapre District, Jayapura Regency, Papua Province, Republic of Indonesia, is uniquely positioned in a region with potentially the largest source of cobalt outside of Africa. Strategically located near China, the world’s largest cobalt buyer, the Cyclops Project is a laterite (iron-hosted) mineral prospect, rich in cobalt and nickel. Cobalt consumption in China is on-track to use over 8,000 tonnes of cobalt annually by 2021 for electric vehicle production alone and is projected to remain the world’s largest cobalt consumer for many years to come.
Global demand for renewable power is fueling a massive shift from traditional energy supply chain economics to cobalt-reliant lithium-ion batteries, the world’s most widely used power source for portable applications such as electric vehicles and other high-tech applications.
Pacific Rim Cobalt management has concluded that strategic access to major markets offers the most important factor to servicing the rising demand for cobalt. The company’s acquisition of its initial asset in Indonesia offers near surface, strong nickel-cobalt mineralization in an area with excellent infrastructure including a nearby workforce, supplies, sealed roads, ocean access, nearby port facility and gentle topography. The project area, nestled on the north coast of Papua, Indonesia, establishes Pacific Rim Cobalt well within the economically attractive ocean-going transportation range to Asia and its lucrative, growing industrial markets.
Exploration efforts are currently focused on establishing a maiden compliant resource for the Cyclops project, both in historically identified and drill-tested prospects as well as previously unexplored areas of the claims. During the first nine months of 2018, the company focused on assembling the necessary agreements to access northern areas of the project hosting historically identified mineralized zones. Mapping, sampling and a mini-bulk sample within the mineralized zones has been completed, along with a small-scale program in the previously unexplored far southern area of the project. With surface access to priority targets now established, Pacific Rim Cobalt will initiate drilling and extract additional mini-bulk samples for further metallurgical testing.
“We are excited and optimistic about the unique possibility of developing this project into an asset that will add shareholder value and position the company to play a future role in the battery metals supply chain,” Pacific Rim Cobalt CEO Ranjeet Sundher recently stated (http://nnw.fm/u1HNs). “We expect the near-surface nature of cobalt/nickel mineralization at the Cyclops project will lend itself well to low-cost, logistically straightforward drilling. We thus anticipate the opportunity to undertake a resource calculation study, as well as ongoing metallurgy and process option testing, will present itself in the near future. It’s going to be a busy year ahead, and we look forward to getting the drills turning and building value.”
Pacific Rim Cobalt’s world-class management team includes Sundher, who has over 20 years of capital markets experience. Sundher is also president of Canrim Ventures Ltd., a Singaporean advisory firm specializing in early stage project finance and structure. He previously founded Indogold Exploration, a Jakarta-based mining service firm, and has raised over $40 million for companies in which he was a founder/partner.
Chief Financial Officer Steve Vanry has 25 years of professional experience in senior management positions with public and private natural resources companies, providing expertise in capital markets corporate finance, mergers and acquisitions, regulatory compliance, accounting and financial reporting.
Andre Talaska serves as country manager and technical supervisor. He has over 30 years of experience in the mining and exploration industry and has held senior positions with several companies in Australia and southeast Asia. Shakir Juffry, business development/engineering, is a chemical engineer and extractive metallurgist by background training who has over 20 years of experience in the Indonesian mining and minerals exploration field. Toto Suarto Sajali, operation and development manager, is a mining engineer with over 15 years of experience in Indonesian project assessment, development and operations.
Pacific Rim Cobalt Corp. (OTCQB: PCRCF), closed Tuesday's trading session at $0.119835, off by 2.1755%, on 65,430 volume with 8 trades. The average volume for the last 3 months is 32,320 and the stock's 52-week low/high is $0.070100001/$0.259299993.
- Pacific Rim Cobalt Corp.’s (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) Ongoing Drill Results Confirm Significant, Near Surface Cobalt and Nickel Mineralization
- Pacific Rim Cobalt Receives Positive Mineral Process Recovery Test Results Averaging 99.6% Nickel and 98.4% Cobalt
- Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) Announces Drilling Results that Confirm and Extend High-Grade Nickel-Cobalt Mineralization
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- B2Digital Inc. (BTDG) Expands Portfolio With Acquisition of Strike Hard Productions MMA, Provides Business Update
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) CEO Rings Nasdaq Opening Bell
- Cannabis Strategic Ventures, Inc. (OTCQB: NUGS) Announces Appointment of New Directors, Chairman to Corporate Board
- Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) 420 with CNW – Radio Frequency Technology Tweaked to Protect Marijuana Quality
- Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) 420 with CNW – Radio Frequency Technology Tweaked to Protect Marijuana Quality
- ChineseInvestors.com (CIIX) Announces 175% Sales Increase, Launch of Six New Hemp-Infused Skincare Products
- Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF) to Acquire 19.9% Equity Interest of Coastal Green, a BC-Based Cannabis Retailer
- City View Green (CSE: CVGR) (OTCQB: LRZZF) Achieves Listing, Commences Trading on OTCQB Venture Market
- CloudCommerce (OTCQB: CLWD) Files to Offer Up to $20M in Reg A+ Preferred Stock as Company Builds Business Analytics Services
- Consorteum Holdings, Inc. (CSRH) Universal Mobile Interface Platform Enables Communication Between Different Platforms and Devices
- Earth Science Tech, Inc. (ETST) Positioning as Key Player in Billion-Dollar Industry
- Endonovo Therapeutics (OTCQB: ENDV) Receives Glowing Video Review on Revolutionary Medical Device
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Enters Strategic Agreement with Leading Chinese Infrared Camera Manufacturer
- Genprex, Inc. (NASDAQ: GNPX) CEO to Present Via Webcast at September 19 Singular Research Midwestern Values Conference
- Geyser Brands Inc. (TSX.V: GYSR) Demonstrates Growth with Encouraging Financial Results
- Grapefruit Boulevard Investments Inc. (IGNG) 420 with CNW – Governor Cuomo Hints Cannabis Smoking Ban Could Be Included in Next Legalization Bill
- Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) Announces Resignation of Board Member
- Green Hygienics Holdings Inc. (GRYN) 420 with CNW – The Benefits of Marijuana During Breast Cancer Treatment
- Hemptown USA - Advances Growth Strategy via Nutraceutical Manufacturing Facility Acquisition
- HTC Extraction Systems (TSX.V: HTC) 420 with CNW – Marijuana Banking Bill Changes Suggested to Win Republican Support
- INmune Bio, Inc. (NASDAQ: INMB) to Present XPro1595 for Treating Neuroinflammation in Alzheimer’s Disease at 2019 Alzheimer’s Association International Conference (AAIC) Satellite Symposium
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) Secures DTC Eligibility for U.S. Markets
- Lexaria Bioscience Corp. (CSE: LXX)(OTC: LXRP) Peer Reviewed Clinical Journal Publishes Lexaria Bioscience's Human CBD Study Results
- Marijuana Company of America Inc. (MCOAD) Completes Reverse Stock Split
- MustGrow Biologics Corp (CSE: MGRO) Obtains Exclusive Rights of Streptomyces Bio-Fungicide Product Used to Treat Powdery Mildew in Cannabis Production
- Neutra Corp. (OTCQB: NTRR) CEO Discusses CBD as Chronic Pain Treatment
- Nightfood, Inc. (OTCQB: NGTF) Delivers Update on Recent Activities and Developments
- Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) Consumer Interest in Cannabis-CBD Infused Products at All Time High
- ORHub Inc. (ORHB) Settles Litigation with Former Chief Financial Officer
- Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) Receives Positive Mineral Process Recovery Test Results Averaging 99.6% Nickel and 98.4% Cobalt
- Pacific Software, Inc. (PFSF) Collaborates with Império for Commercial Marketing and Promotion of BOAPIN.com Trade Portal
- Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) Demonstrates Potential of Clean-Oil Recovery Technology
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Debuts Hemp-CBD Edible Line, Partners with John Legend
- Predictive Oncology Inc. (NASDAQ: POAI) Transforming Cancer-Treatment Outcomes via Proprietary Database
- Pressure BioSciences Inc. (PBIO) Discusses Major Advancements Its PCT, BaroFold, and BaroShear K45 Platforms
- Quest Patent Research Corp. (QPRC) Holds Broad Portfolio of Intellectual Property Assets
- Sharing Services Global Corporation (SHRG) Assists in Independent Distributors’ Success
- SinglePoint, Inc. (SING) CEO Discusses Hemp Cigarette Product on MoneyTV with Donald Baillargeon
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Receives $800,000 Purchase Order for its UR7 Rugged Clamshell Handset
- Spectrum Global Solutions, Inc. (SGSI) Prepared to Support 5G Technology
- Sproutly Canada, Inc. (OTC: SRUTF) (CSE: SPR) (FRA: 38G) Announces Expansion With New Manufacturing Facility
- SRAX Inc. (NASDAQ: SRAX) Big Brands Embrace BIGtoken Platform with Integrated Big Rewards™ Programs
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) CEO to Participate at September 17 Battery Next Summit in Boulder, CO
- Sugarmade, Inc. (SGMD) 420 with CNW – Medical Marijuana Prices in Michigan Rise as Recreational Sales Near
- The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Multiple Reports Agree That Cannabis Market Growth Shows No Signs of Slowing
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Hosts Analyst Site Visit at Hamilton and Valleyfield Facilities
- Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) 420 with CNW – Mexican Senate to Start Debating Cannabis Legalization This Week
- TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) Completes SolDaze Acquisition
- Trxade Group Inc. (TRXD) Tech Solutions Like Those from Trxade Group Can Help Independent Pharmacies Thrive in the Future
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) Announces Partnership with Linneo Health to Supply Medical Cannabis in Europe
- VPR Brands, LP (VPRB) Seeks to Protect Patented Auto-Draw Technology as Vaping Industry Booms
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Developing Robust Retail Network for CBD Products
- Willow Biosciences Inc. (CSE: WLLW) 420 with CNW – Massachusetts Lawmakers Move to Address Vaping Dangers
- Xalles Holdings Inc. (XALL) Targets Growing B2B Financial Reconciliation Market
- Youngevity International, Inc. (NASDAQ: YGYI) Announces Pricing of $7.25M Underwritten Public Offering
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.